Explore 3 Stock Ideas & Industry Insights Download Free Report

Cheelcare Inc.

Healthcare CA CHER

1.55CAD
0.00(0%)

Last update at 2026-06-12T19:58:00Z

Day Range

1.501.71
LowHigh

52 Week Range

0.831.98
LowHigh

Fundamentals

  • Previous Close 1.55
  • Market Cap34.15M
  • Volume36150
  • P/E Ratio-
  • Dividend Yield-%
  • EBITDA-1.72901M
  • Revenue TTM1.63M
  • Revenue Per Share TTM0.18
  • Gross Profit TTM 0.80M
  • Diluted EPS TTM-0.18

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Financials

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2025-04-30 2024-04-30 2023-04-30
Type yearly yearly yearly
Date 2025-04-30 2024-04-30 2023-04-30
Income before tax -1.27004M -0.54084M -0.12646M
Minority interest - - -
Net income -1.27004M -0.54084M -0.12646M
Selling general administrative 0.07M 0.72M 0.37M
Selling and marketing expenses - - -
Gross profit 0.80M 0.77M 0.58M
Reconciled depreciation 0.05M 0.00390M 0.00533M
Ebit -1.32558M - -
Ebitda - - -
Depreciation and amortization - - -
Non operating income net other - - -
Operating income -1.32558M -0.29617M 0.08M
Other operating expenses - - -
Interest expense 0.28M 0.19M 0.16M
Tax provision 0.00000M - -
Interest income - - -
Net interest income -0.31999M -0.24603M -0.20374M
Extraordinary items - - -
Non recurring - - -
Other items - - -
Income tax expense - - -
Total revenue 1.57M 1.44M 1.11M
Total operating expenses 2.12M 1.73M 1.03M
Cost of revenue 0.77M 0.67M 0.53M
Total other income expense net 0.00810M 0.00136M -
Discontinued operations - - -
Net income from continuing ops -1.27004M -0.54084M -0.12646M
Net income applicable to common shares -1.27004M - -
Preferred stock and other adjustments - - -
Breakdown 2025-04-30 2024-04-30 2023-04-30
Type yearly yearly yearly
Date 2025-04-30 2024-04-30 2023-04-30
Total assets 4.17M 0.60M 0.38M
Intangible assets 0.02M 0.02M 0.02M
Earning assets - - -
Other current assets - - -
Total liab 7.33M 2.95M 2.27M
Total stockholder equity 0.07M -2.35535M -1.88608M
Deferred long term liab - - -
Other current liab 3.60M - -
Common stock 0.26M - -
Capital stock 0.49M 0.49M 0.49M
Retained earnings -0.18978M -3.05697M -2.51613M
Other liab - - -
Good will - - -
Other assets - - -
Cash 0.03M 0.07M 0.04M
Cash and equivalents - - -
Total current liabilities 0.04M 1.13M 0.56M
Current deferred revenue - - -
Net debt 2.06M 1.46M 1.07M
Short term debt 0.00000M - -
Short long term debt 1.62M 0.18M 0.09M
Short long term debt total - - -
Other stockholder equity - - -
Property plant equipment - - -
Total current assets 4.09M 0.57M 0.35M
Long term investments - - -
Net tangible assets - - -
Short term investments - - -
Net receivables 0.14M 0.13M 0.08M
Long term debt 0.49M 1.35M 1.02M
Inventory 0.29M 0.33M 0.20M
Accounts payable 0.89M 0.48M 0.16M
Total permanent equity - - -
Noncontrolling interest in consolidated entity - - -
Temporary equity redeemable noncontrolling interests - - -
Accumulated other comprehensive income - - -
Additional paid in capital - - -
Common stock total equity - - -
Preferred stock total equity - - -
Retained earnings total equity - - -
Treasury stock - - -
Accumulated amortization - - -
Non currrent assets other - - -
Deferred long term asset charges - - -
Non current assets total 0.08M 0.03M 0.03M
Capital lease obligations - - -
Long term debt total 0.00000M - -
Breakdown 2025-04-30 2024-04-30 2023-04-30
Type yearly yearly yearly
Date 2025-04-30 2024-04-30 2023-04-30
Investments - -0.00227M 0.00000M
Change to liabilities - - -
Total cashflows from investing activities -0.01223M - -
Net borrowings 0.67M - -
Total cash from financing activities 4.00M 0.24M 0.05M
Change to operating activities - - -
Net income -0.06597M -0.54084M -0.12646M
Change in cash -0.11949M 0.03M 0.02M
Begin period cash flow 0.07M 0.04M 0.02M
End period cash flow 3.56M 0.07M 0.04M
Total cash from operating activities -0.49595M -0.21077M -0.02989M
Issuance of capital stock - - -
Depreciation 0.05M 0.00390M 0.00533M
Other cashflows from investing activities -0.07500M - -
Dividends paid - - -
Change to inventory -0.03119M -0.12979M 0.01M
Change to account receivables - - -
Sale purchase of stock - - -
Other cashflows from financing activities - - -
Change to netincome - - -
Capital expenditures 0.01M 0.00227M 0.00000M
Change receivables - - -
Cash flows other operating - - -
Exchange rate changes - - -
Cash and cash equivalents changes - - -
Change in working capital 0.33M 0.28M 0.03M
Stock based compensation 0.33M 0.00373M 0.00000M
Other non cash items 0.07M 0.04M 0.06M
Free cash flow -0.50818M -0.21304M -0.02989M

Peer Comparison

Sector: Healthcare Industry: Medical Devices

Company Change (CAD) Price (CAD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x)
CHER
Cheelcare Inc.
- -% 1.55 - - 20.92 106.42 21.26
TLT
Theralase Technologies Inc.
-0.005 2.08% 0.23 - - 90.07 82.51 90.31 -12.0585
CNVI
Conavi Medical Corp.
0.005 2.08% 0.24 - - 66.65 - 95.30
PINK
Perimeter Medical Imaging AI Inc
0.005 1.72% 0.29 4.13 - 18.78 11.34 20.22 -2.5521
ASG
Aurora Spine Corp
- -% 0.23 - - 1.19 4.07 1.02 202.96

Reports Covered

Stock Research & News

Profile

Cheelcare Inc. develops, manufactures, and distributes assistive mobility devices. It offers robotic complex rehab power wheelchairs, power add-ons for manual wheelchairs, and wheelchair accessories. The company is based in Richmond Hill, Canada.

Cheelcare Inc.

16 Sims Crescent, Richmond Hill, ON, Canada, L4B2P1

Key Executives

Name Title Year Born
Mr. Eugene Cherny Founder & CEO, Director NA
Mr. Dima Paltsev Founder & CFO, Director, corporate secretary NA
Mr. Allex Laurin Director of Marketing NA
Mr. Gennadiy Lisnyak Chief Mechanical Engineer NA
Mr. Yevgeny Cherny Founder & CEO, Director NA
Mr. Dmitry Paltsev Founder & CFO, Director, corporate secretary NA
Mr. Dmitry Paltsev Founder, Director & Corporate Secretary NA
Ms. Natasha Tsai C.A., CPA Chief Financial Officer 1981
Dmitry Marukh Director of Research & Development NA
Allan Boyd Vice President of Growth NA

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.